The deadly pharma factory blast in Telangana has so far taken the lives of 44 people; rendering it one of the deadliest industrial accidents in the history of the state. The blast happened on June 30 at the pharmaceutical excipient producer Sigachi..

Biosimilar market in India is poised to boom in 2025, due to increasing rates of chronic diseases, patent expiration, and also a favorable policy environment. Within the domestic revenue, the biosimilars portion grew from roughly USD 866 million

Celebrate Doctor’s Day with expert-backed, breakthrough healthcare strategies doctors swear by—real tips for real wellness...

The pharmaceutical companies in India are under immense change. Until it was known for the generic pharmacy provided medicines, India is now the hotspot for pharmaceutical research, innovation, and manufacturing.

The Indian pharma sector is experiencing a remarkable shift, growing from the cost-driven outsourcing model into a bustling center of innovation, research, and international alliances.

The pharmaceutical industry, highly influenced by international health priorities, is struggling with one of the biggest issues: ensuring that the pharmaceutical supply chains are secure, transparent, and trustworthy...